Theodore T. Wang, Director, 10% Owner at Bellerophon Therapeutics, Inc. (BLPH), bought 8,443 shares at $0.39 ($3K) on 2019-11-25, disclosed to the SEC on 2019-11-25.
Open-market purchase of $3k BLPH by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.37 | 200 | $74 | 2.3% |
| 2 | $0.37 | 1,050 | $389 | 11.9% |
| 3 | $0.39 | 7,193 | $3K | 85.8% |
| Total | $0.39 avg | 8,443 | $3K | 100% |
| Filing → |
| BLPH | BUY | 2019-05-24 | $17K | — | Filing → |
| BLPH | BUY | 2019-05-22 | $26K | — | Filing → |
| BLPH | BUY | 2019-01-25 | $315K | — | Filing → |